An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

GENETIC: HEMGENIX
BIOLOGICAL: Factor IX (FIX)

Sponsor

CSL Behring